Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2011 Sep;44(6):515-23.
doi: 10.1002/eat.20849. Epub 2010 Oct 18.

Predictive significance of changes in dietary restraint in obese patients with binge eating disorder during treatment

Affiliations
Randomized Controlled Trial

Predictive significance of changes in dietary restraint in obese patients with binge eating disorder during treatment

Kerstin K Blomquist et al. Int J Eat Disord. 2011 Sep.

Abstract

Objective: To examine whether changes in different aspects of dietary restraint in obese patients with binge eating disorder (BED) participating in a treatment study predict outcomes.

Method: Fifty obese patients with BED in a randomized controlled study of orlistat administered with cognitive-behavioral therapy, guided-self-help (CBTgsh) completed dietary restraint measures at baseline, during- and post-treatment, and three-month follow-up.

Results: Change in the restraint scale of the Eating Disorder Examination-Questionnaire did not predict binge abstinence or 5% weight loss. Increased flexible restraint subscale of the Three Factor Eating Questionnaire (TFEQ) during treatment significantly predicted binge abstinence at post-treatment and three-month follow-up and 5% weight loss at post-treatment. Change in the rigid restraint subscale of the TFEQ predicted binge abstinence at post-treatment.

Discussion: Our findings clarify further pathologic and adaptive aspects of restraint and suggest the importance of enhancing flexible restraint in order to improve both binge eating and weight loss outcomes.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mean TFEQ flexible restraint scores for binge abstainers and binge non-abstainers at pre-treatment, post-treatment (PT) and 3-month follow-up (FU) Note: PT-Yes represents binge abstainers at post-treatment; PT-No represents binge non-abstainers at post-treatment; FU-Yes represents binge abstainers at 3-month follow-up; FU-No represents binge non-abstainers at 3-month follow-up.
Figure 2
Figure 2
Mean TFEQ flexible restraint scores for patients who did and did not achieve 5% weight loss at pre-treatment, post-treatment (PT), and 3-month follow-up (FU) Note: PT-Yes represents patients who achieved 5% weight loss at post-treatment; PT-No represents patients who did not achieve 5% weight loss at post-treatment; FU-Yes represents patients who achieved 5% weight loss at 3-month follow-up; FU-No represents patients who did achieve 5% weight loss at 3-month follow-up.

References

    1. Hudson JI, Hiripi E, Pope HG, Kessler RC. The prevalence and correlates of eating disorders in the NCS Replication. Biol Psychiatry. 2007;61:348–358. - PMC - PubMed
    1. Grilo CM, Hrabosky JI, Allison KC, Stunkard AJ, Masheb RM. Overvaluation of shape and weight in binge eating disorder and overweight controls: Refinement of a diagnostic construct. J Abnorm Psychol. 2008;117:414–419. - PMC - PubMed
    1. Grilo CM, Crosby RD, Masheb RM, et al. Overvaluation of shape and weight in binge eating disorder, bulimia nervosa, and suthreshold bulimia nervosa. Behav Res Ther. 2009;47:692–696. - PMC - PubMed
    1. Wilson GT, Grilo CM, Vitousek KM. Psychological treatments of eating disorders. Am Psychol. 2007;72:199–216. - PubMed
    1. Reas DL, Grilo CM. Review and meta-analysis of pharmacotherapy for binge eating disorder. Obesity. 2008;16:2024–2038. - PMC - PubMed

Publication types

MeSH terms